loader
Please Wait
Applying Filters...

Seqens Seqens

X

List of All Manufacturers & Suppliers for 22260 Licensing, EU CTD Dossiers, Marketing Authorizations, Finished Dosage Formulations listed on PharmaCompass.com

Client Virtual Booth
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 EPOPROSTENOL SODIUM (2)

filter

01 ACTELION (2)

filter

01 INJECTABLE;INJECTION (2)

filter

01 EQ 0.5MG BASE/VIAL (1)

02 EQ 1.5MG BASE/VIAL (1)

filter

01 USA (2)

URL Supplier Web Content
INJECTABLE;INJECTION
EQ 0.5MG BASE/VIAL
VELETRI
USA
22260
2012-06-28
RX
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
INJECTABLE;INJECTION
EQ 1.5MG BASE/VIAL
VELETRI
USA
22260
2008-06-27
RX
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for CTD TGA MCC DOSSIER APPLICATION 22260

Looking for CTD TGA MCC DOSSIER APPLICATION 22260 2

19

Actelion Pharmaceuticals Ltd, based in Switzerland, is a pharmaceutical company.

One of their notable products is EPOPROSTENOL SODIUM, with a corresponding application number 22260 and regulatory information .

proudly manufactured in the

approval since 2012-06-28

Actelion Pharmaceuticals Ltd's VELETRI INJECTABLE;INJECTION, medication with EQ 0.5MG BASE/VIAL of EPOPROSTENOL SODIUM.

18

Actelion Pharmaceuticals Ltd, based in Switzerland, is a pharmaceutical company.

One of their notable products is EPOPROSTENOL SODIUM, with a corresponding application number 22260 and regulatory information .

proudly manufactured in the

approval since 2008-06-27

Actelion Pharmaceuticals Ltd's VELETRI INJECTABLE;INJECTION, medication with EQ 1.5MG BASE/VIAL of EPOPROSTENOL SODIUM.

Post Enquiry
POST ENQUIRY